SCHEMBL11046114

SCHEMBL11046114

C#C[C@]1(OC(=O)C(F)(F)F)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 6/20 0.79
▸ ABCB11 O95342 5/20 0.79
▸ PGR P06401 5/20 0.79
▸ CYP2C19 P33261 4/20 0.79
▸ AR P10275 4/20 0.79
▸ NR3C1 P04150 3/20 0.79
▸ MEN1 O00255 3/20 0.79
▸ KMT2A Q03164 3/20 0.79
▸ MAPT P10636 2/20 0.79
▸ ADORA3 P0DMS8 2/20 0.79
▸ CHRM1 P11229 2/20 0.79
▸ SLC6A2 P23975 2/20 0.79
▸ ADRA1A P35348 2/20 0.79
▸ MAPK1 P28482 2/20 0.79
▸ CHRM2 P08172 1/20 0.79
▸ TBXA2R P21731 1/20 0.79
▸ LMNA P02545 5/20 0.63
▸ ESR1 P03372 3/20 0.63
▸ SLC6A4 P31645 3/20 0.63
▸ SHBG P04278 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10821091 0.89 ABCB11 (0.63) CYP3A4ABCB11PGRCYP2C19AR
Norethindrone Acetate SCHEMBL1232662 0.89 CYP3A4 (1.00) CYP3A4ABCB11PGRCYP2C19AR
Norethindrone Acetate SCHEMBL11321479 0.89 CYP3A4 (1.00) CYP3A4ABCB11PGRCYP2C19AR
Norethindrone Acetate SCHEMBL14074495 0.89 CYP3A4 (1.00) CYP3A4ABCB11PGRCYP2C19AR
Norethindrone Acetate SCHEMBL14360522 0.89 CYP3A4 (1.00) CYP3A4ABCB11PGRCYP2C19AR
Norethindrone Acetate SCHEMBL37530 0.89 CYP3A4 (1.00) CYP3A4ABCB11PGRCYP2C19AR
Norethindrone Acetate SCHEMBL14577826 0.89 CYP3A4 (1.00) CYP3A4ABCB11PGRCYP2C19AR
SCHEMBL11291553 0.89 CYP3A4 (0.85) CYP3A4ABCB11PGRCYP2C19AR
SCHEMBL9473282 0.88 CYP3A4 (0.84) CYP3A4ABCB11PGRCYP2C19AR
SCHEMBL8853605 0.87 CYP3A4 (0.82) CYP3A4ABCB11PGRCYP2C19AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0063368-B1 PROCESS FOR THE PREPARATION OF PREGN-4-ENE-3,20-DIONE DERIVATIVES AND 17-ALPHA-ETHYNYL-17-BETA-TRIFLUOROACETOXY-GON-4-ENE-3-ONE DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE LATTER COMPOUNDS RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1984-07-25 — — EP claimed
US-4482494-A Process for preparing 17α-hydroxy-pregn-4-en-3,20-dione RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1984-11-13 — — US disclosed
US-4368160-A Process for preparing 17α-hydroxy-pregn-4-en-3,20-dione derivatives RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1983-01-11 — — US disclosed
Send feedback